Quantbot Technologies LP Purchases New Shares in Alignment Healthcare, Inc. $ALHC

Quantbot Technologies LP purchased a new position in shares of Alignment Healthcare, Inc. (NASDAQ:ALHC) in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 69,727 shares of the company’s stock, valued at approximately $1,660,000.

Other institutional investors also recently bought and sold shares of the company. Vanguard Group Inc. boosted its stake in shares of Alignment Healthcare by 10.9% during the fourth quarter. Vanguard Group Inc. now owns 15,492,802 shares of the company’s stock worth $305,983,000 after buying an additional 1,524,218 shares during the period. Wellington Management Group LLP increased its position in Alignment Healthcare by 26.9% in the 4th quarter. Wellington Management Group LLP now owns 14,070,893 shares of the company’s stock valued at $277,900,000 after acquiring an additional 2,981,166 shares during the period. T. Rowe Price Investment Management Inc. raised its stake in Alignment Healthcare by 0.6% during the 4th quarter. T. Rowe Price Investment Management Inc. now owns 12,643,784 shares of the company’s stock valued at $249,715,000 after acquiring an additional 79,268 shares during the last quarter. William Blair Investment Management LLC purchased a new stake in Alignment Healthcare during the 2nd quarter valued at approximately $184,799,000. Finally, Invesco Ltd. lifted its position in Alignment Healthcare by 38.9% during the 4th quarter. Invesco Ltd. now owns 6,202,592 shares of the company’s stock worth $122,501,000 after acquiring an additional 1,735,962 shares during the period. 86.19% of the stock is currently owned by institutional investors and hedge funds.

Alignment Healthcare Trading Up 2.1%

Shares of Alignment Healthcare stock opened at $13.43 on Tuesday. The company has a 50-day moving average of $18.71 and a two-hundred day moving average of $18.73. Alignment Healthcare, Inc. has a 12-month low of $12.70 and a 12-month high of $25.12. The company has a current ratio of 1.70, a quick ratio of 1.70 and a debt-to-equity ratio of 1.22. The stock has a market cap of $2.79 billion, a PE ratio of 70.69 and a beta of 1.10.

Alignment Healthcare (NASDAQ:ALHC) last announced its quarterly earnings results on Thursday, July 30th. The company reported $0.17 EPS for the quarter, topping the consensus estimate of $0.13 by $0.04. The business had revenue of $1.34 billion for the quarter, compared to analyst estimates of $1.31 billion. Alignment Healthcare had a return on equity of 20.02% and a net margin of 0.89%.The company’s quarterly revenue was up 31.6% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.07 EPS. On average, research analysts anticipate that Alignment Healthcare, Inc. will post 0.17 EPS for the current fiscal year.

Analyst Ratings Changes

Several brokerages have weighed in on ALHC. Weiss Ratings reiterated a “hold (c-)” rating on shares of Alignment Healthcare in a research note on Tuesday, August 4th. Raymond James Financial cut Alignment Healthcare from a “strong-buy” rating to an “outperform” rating and cut their price target for the stock from $22.00 to $19.00 in a research note on Monday, August 3rd. UBS Group reaffirmed a “neutral” rating on shares of Alignment Healthcare in a report on Wednesday, July 8th. JPMorgan Chase & Co. lowered their price objective on shares of Alignment Healthcare from $26.00 to $22.00 and set an “overweight” rating on the stock in a research report on Tuesday, August 4th. Finally, KeyCorp reissued an “overweight” rating on shares of Alignment Healthcare in a research note on Wednesday, June 10th. Seven research analysts have rated the stock with a Buy rating and four have given a Hold rating to the stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $23.60.

Insider Activity at Alignment Healthcare

In other news, EVP Joseph S. Konowiecki sold 25,000 shares of Alignment Healthcare stock in a transaction on Wednesday, July 1st. The stock was sold at an average price of $24.00, for a total transaction of $600,000.00. Following the completion of the transaction, the executive vice president owned 1,103,816 shares of the company’s stock, valued at $26,491,584. The trade was a 2.21% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, President Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare stock in a transaction on Monday, June 15th. The stock was sold at an average price of $19.55, for a total value of $586,500.00. Following the transaction, the president directly owned 947,313 shares of the company’s stock, valued at $18,519,969.15. This trade represents a 3.07% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 1,009,951 shares of company stock valued at $18,597,287 in the last 90 days. 5.20% of the stock is owned by corporate insiders.

Alignment Healthcare Profile

Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.

At the core of Alignment Healthcare’s approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.